<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34360808</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>15</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8042</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22158042</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive disease leading to the degeneration of motor neurons (MNs). Neuroinflammation is involved in the pathogenesis of ALS; however, interactions of specific immune cell types and MNs are not well studied. We recently found a shift toward T helper (Th)1/Th17 cell-mediated, pro-inflammatory immune responses in the peripheral immune system of ALS patients, which positively correlated with disease severity and progression. Whether Th17 cells or their central mediator, Interleukin-17 (IL-17), directly affects human motor neuron survival is currently unknown. Here, we evaluated the contribution of Th17 cells and IL-17 on MN degeneration using the co-culture of iPSC-derived MNs of fused in sarcoma (FUS)-ALS patients and isogenic controls with Th17 lymphocytes derived from ALS patients, healthy controls, and multiple sclerosis (MS) patients (positive control). Only Th17 cells from MS patients induced severe MN degeneration in FUS-ALS as well as in wildtype MNs. Their main effector, IL-17A, yielded in a dose-dependent decline of the viability and neurite length of MNs. Surprisingly, IL-17F did not influence MNs. Importantly, neutralizing IL-17A and anti-IL-17 receptor A treatment reverted all effects of IL-17A. Our results offer compelling evidence that Th17 cells and IL-17A do directly contribute to MN degeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Mengmeng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Neuroscience, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akg&#xfc;n</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Neuroscience, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziemssen</LastName><ForeName>Tjalf</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-8799-8202</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical Neuroscience, University Hospital Carl Gustav Carus, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kipp</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5043-9052</Identifier><AffiliationInfo><Affiliation>Institute of Anatomy, University Medical Center Rostock, Gertrudenstrasse 9, 18057 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences, University Medical Center Rostock, 18057 Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Rene</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0329-5644</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7364-7791</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, 01307 Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Transdisciplinary Neurosciences, University Medical Center Rostock, 18057 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Neurodegeneration Section, "Albrecht-Kossel", Department of Neurology, University Medical Center Rostock, 18057 Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>not applicable</GrantID><Agency>Hermann und Lilly Schilling-Stiftung f&#xfc;r Medizinische Forschung</Agency><Country/></Grant><Grant><GrantID>n.a.</GrantID><Agency>NOMIS Stiftung</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508717">IL17A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C440021">IL17F protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020381">Interleukin-17</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="N">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020381" MajorTopicYN="N">Interleukin-17</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058504" MajorTopicYN="N">Th17 Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Th17 cell</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">fused in sarcoma</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">interleukin-17</Keyword><Keyword MajorTopicYN="N">motor neuron</Keyword><Keyword MajorTopicYN="N">multiple sclerosis</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34360808</ArticleId><ArticleId IdType="pmc">PMC8348495</ArticleId><ArticleId IdType="doi">10.3390/ijms22158042</ArticleId><ArticleId IdType="pii">ijms22158042</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P., Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G., Gautier O., Tassoni-Tsuchida E., Ma X.R., Gitler A.D. ALS Genetics: Gains, Losses, and Implications for Future Therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Goizet C., Soulages A., Vallat J.M., Masson G.L. Genetics of amyotrophic lateral sclerosis: A review. J. Neurol. Sci. 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Ciura S., Rouleau G.A., Kabashi E. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD) Trends Genet. 2015;31:263&#x2013;273. doi: 10.1016/j.tig.2015.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2015.03.005</ArticleId><ArticleId IdType="pubmed">25869998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubers A., Just W., Rosenbohm A., Muller K., Marroquin N., Goebel I., Hogel J., Thiele H., Altmuller J., Nurnberg P., et al. De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients. Neurobiol. Aging. 2015;36:3117.e1&#x2013;3117.e6. doi: 10.1016/j.neurobiolaging.2015.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.08.005</ArticleId><ArticleId IdType="pubmed">26362943</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y., Huang E.J. Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis. Brain Res. 2016;1647:65&#x2013;78. doi: 10.1016/j.brainres.2016.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.03.036</ArticleId><ArticleId IdType="pmc">PMC5003642</ArticleId><ArticleId IdType="pubmed">27033831</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Wang H., Cai Y., Wen H., Wang L., Zhu M., Chen Y., Yu Y., Lu X., Zhou M., et al. FUS P525L mutation causing amyotrophic lateral sclerosis and movement disorders. Brain Behav. 2020;10:e01625. doi: 10.1002/brb3.1625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.1625</ArticleId><ArticleId IdType="pmc">PMC7303404</ArticleId><ArticleId IdType="pubmed">32307925</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki Y., Isozaki E., Takao M., Hashimoto T., Shibuya M., Arai M., Hosokawa M., Kawata A., Oyanagi K., Mihara B., et al. Familial ALS with FUS P525L mutation: Two Japanese sisters with multiple systems involvement. J. Neurol. Sci. 2012;323:85&#x2013;92. doi: 10.1016/j.jns.2012.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.08.016</ArticleId><ArticleId IdType="pubmed">22980027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte A., Lattante S., Zollino M., Marangi G., Luigetti M., Del Grande A., Servidei S., Trombetta F., Sabatelli M. P525L FUS mutation is consistently associated with a severe form of juvenile amyotrophic lateral sclerosis. Neuromuscul. Disord. 2012;22:73&#x2013;75. doi: 10.1016/j.nmd.2011.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2011.08.003</ArticleId><ArticleId IdType="pubmed">21907581</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Peikert K., Gunther R., van der Kooi A.J., Aronica E., Hubers A., Danel V., Corcia P., Pan-Montojo F., Cirak S., et al. Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2019;6:2384&#x2013;2394. doi: 10.1002/acn3.50930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50930</ArticleId><ArticleId IdType="pmc">PMC6917314</ArticleId><ArticleId IdType="pubmed">31682085</ArticleId></ArticleIdList></Reference><Reference><Citation>Beland L.C., Markovinovic A., Jakovac H., De Marchi F., Bilic E., Mazzini L., Kriz J., Munitic I. Immunity in amyotrophic lateral sclerosis: Blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020;2:fcaa124. doi: 10.1093/braincomms/fcaa124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa124</ArticleId><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon M.S., Wosiski-Kuhn M., Gillespie R., Caress J., Milligan C. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve. 2019;59:10&#x2013;22. doi: 10.1002/mus.26289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26289</ArticleId><ArticleId IdType="pubmed">29979464</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller K.J., Restrepo C.R., Khan T., Dominique M.A., Fang T.C., Canter R.G., Roberts C.J., Miller K.R., Ransohoff R.M., Trojanowski J.Q., et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 2018;21:329&#x2013;340. doi: 10.1038/s41593-018-0083-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0083-7</ArticleId><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S.J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS. Exp. Neurobiol. 2016;25:233&#x2013;240. doi: 10.5607/en.2016.25.5.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmoy T. T cells in amyotrophic lateral sclerosis. Eur. J. Neurol. 2008;15:360&#x2013;366. doi: 10.1111/j.1468-1331.2008.02065.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2008.02065.x</ArticleId><ArticleId IdType="pubmed">18266871</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Beers D.R., Wen S., Rivera A.L., Toennis K.M., Appel J.E., Zhao W., Moore D.H., Powell S.Z., Appel S.H. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 2013;5:64&#x2013;79. doi: 10.1002/emmm.201201544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201544</ArticleId><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M., Evangelopoulos E., Sereti E., Zouvelou V., Marmara S., Alexakis T., Evdokimidis I. Alterations of T cell subsets in ALS: A systemic immune activation? Acta Neurol. Scand. 2012;125:260&#x2013;264. doi: 10.1111/j.1600-0404.2011.01528.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2011.01528.x</ArticleId><ArticleId IdType="pubmed">21651502</ArticleId></ArticleIdList></Reference><Reference><Citation>Saresella M., Piancone F., Tortorella P., Marventano I., Gatti A., Caputo D., Lunetta C., Corbo M., Rovaris M., Clerici M. T helper-17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis. Clin. Immunol. 2013;148:79&#x2013;88. doi: 10.1016/j.clim.2013.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2013.04.010</ArticleId><ArticleId IdType="pubmed">23665549</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaddatz H., Joost S., Nedelcu J., Chrzanowski U., Schmitz C., Gingele S., Gudi V., Stangel M., Zhan J., Santrau E., et al. Cuprizone-induced demyelination triggers a CD8-pronounced T cell recruitment. Glia. 2020;69:925&#x2013;942. doi: 10.1002/glia.23937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23937</ArticleId><ArticleId IdType="pubmed">33245604</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheld M., R&#xfc;ther B.J., Gro&#xdf;e-Veldmann R., Ohl K., Tenbrock K., Dreym&#xfc;ller D., Fallier-Becker P., Zendedel A., Beyer C., Clarner T., et al. Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain. J. Neurosci. 2016;36:1410&#x2013;1415. doi: 10.1523/JNEUROSCI.2456-15.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2456-15.2016</ArticleId><ArticleId IdType="pmc">PMC6604825</ArticleId><ArticleId IdType="pubmed">26818526</ArticleId></ArticleIdList></Reference><Reference><Citation>Na S.Y., Hermann A., Sanchez-Ruiz M., Storch A., Deckert M., Hunig T. Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells. Immunity. 2012;37:134&#x2013;146. doi: 10.1016/j.immuni.2012.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.04.009</ArticleId><ArticleId IdType="pubmed">22683122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruther B.J., Scheld M., Dreymueller D., Clarner T., Kress E., Brandenburg L.O., Swartenbroekx T., Hoornaert C., Ponsaerts P., Fallier-Becker P., et al. Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression. Glia. 2017;65:1900&#x2013;1913. doi: 10.1002/glia.23202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23202</ArticleId><ArticleId IdType="pubmed">28836302</ArticleId></ArticleIdList></Reference><Reference><Citation>Chrzanowski U., Bhattarai S., Scheld M., Clarner T., Fallier-Becker P., Beyer C., Rohr S.O., Schmitz C., Hochstrasser T., Schweiger F., et al. Oligodendrocyte degeneration and concomitant microglia activation directs peripheral immune cells into the forebrain. Neurochem. Int. 2019;126:139&#x2013;153. doi: 10.1016/j.neuint.2019.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2019.03.005</ArticleId><ArticleId IdType="pubmed">30867127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni A., Yang T., Mesnard-Hoaglin N.A., Gutierrez R., Stubbs E.B., Jr., McGuire S.O., Sanders V.M., Jones K.J., Foecking E.M., Xin J. Th17 Cell Response in SOD1G93A Mice following Motor Nerve Injury. Mediat. Inflamm. 2016;2016:6131234. doi: 10.1155/2016/6131234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6131234</ArticleId><ArticleId IdType="pmc">PMC4852359</ArticleId><ArticleId IdType="pubmed">27194826</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala M., Chattopadhay M., La Cava A., Tse E., Liu G., Lourenco E., Eskin A., Liu P.T., Magpantay L., Tse S., et al. IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. J. Neuroinflamm. 2010;7:76. doi: 10.1186/1742-2094-7-76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-76</ArticleId><ArticleId IdType="pmc">PMC2992053</ArticleId><ArticleId IdType="pubmed">21062492</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M., Rombos A., Nikolaou C., Zoga M., Zouvelou V., Dimitrakopoulos A., Alexakis T., Tsoutsou A., Samakovli A., Michalopoulou M., et al. Interleukin-17 and interleukin-23 are elevated in serum and cerebrospinal fluid of patients with ALS: A reflection of Th17 cells activation? Acta Neurol. Scand. 2010;122:425&#x2013;429. doi: 10.1111/j.1600-0404.2010.01333.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2010.01333.x</ArticleId><ArticleId IdType="pubmed">20219021</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M., Gunther R., Akgun K., Hermann A., Ziemssen T. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci. Rep. 2020;10:5941. doi: 10.1038/s41598-020-62756-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62756-8</ArticleId><ArticleId IdType="pmc">PMC7125229</ArticleId><ArticleId IdType="pubmed">32246039</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee G., Studer L. Induced pluripotent stem cell technology for the study of human disease. Nat. Methods. 2010;7:25&#x2013;27. doi: 10.1038/nmeth.f.283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.f.283</ArticleId><ArticleId IdType="pubmed">20038952</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Sances S., Workman M.J., Svendsen C.N. Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery. Cell Stem Cell. 2020;26:309&#x2013;329. doi: 10.1016/j.stem.2020.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.02.011</ArticleId><ArticleId IdType="pmc">PMC7159985</ArticleId><ArticleId IdType="pubmed">32142662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiter N., Pal A., Lojewski X., Corcia P., Naujock M., Reinhardt P., Sterneckert J., Petri S., Wegner F., Storch A., et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol. Dis. 2018;115:167&#x2013;181. doi: 10.1016/j.nbd.2018.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.03.010</ArticleId><ArticleId IdType="pubmed">29630989</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal A., Kretner B., Abo-Rady M., Glabeta H., Dash B.P., Naumann M., Japtok J., Kreiter N., Dhingra A., Heutink P., et al. Concomitant gain and loss of function pathomechanisms in C9ORF72 amyotrophic lateral sclerosis. Life Sci. Alliance. 2021;4 doi: 10.26508/lsa.202000764.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000764</ArticleId><ArticleId IdType="pmc">PMC7918691</ArticleId><ArticleId IdType="pubmed">33619157</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J., Lojewski X., Naumann M., Klingenstein M., Reinhardt P., Sterneckert J., Putz S., Demestre M., Boeckers T.M., Ludolph A.C., et al. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol. Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T., Akiyama H., Yamada T., McGeer P.L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 1992;140:691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M., Pal A., Goswami A., Lojewski X., Japtok J., Vehlow A., Naujock M., G&#xfc;nther R., Jin M., Stanslowsky N., et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat. Commun. 2018;9:335. doi: 10.1038/s41467-017-02299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou W., Restifo N.P. T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 2010;10:248&#x2013;256. doi: 10.1038/nri2742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2742</ArticleId><ArticleId IdType="pmc">PMC3242804</ArticleId><ArticleId IdType="pubmed">20336152</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C., Wu L., Li X. IL-17 family: Cytokines, receptors and signaling. Cytokine. 2013;64:477&#x2013;485. doi: 10.1016/j.cyto.2013.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2013.07.022</ArticleId><ArticleId IdType="pmc">PMC3867811</ArticleId><ArticleId IdType="pubmed">24011563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zepp J., Wu L., Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 2011;32:232&#x2013;239. doi: 10.1016/j.it.2011.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2011.02.007</ArticleId><ArticleId IdType="pmc">PMC3329781</ArticleId><ArticleId IdType="pubmed">21493143</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: Role of glial activation in motor neuron disease. Lancet Neurol. 2011;10:253&#x2013;263. doi: 10.1016/S1474-4422(11)70015-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez M.J., Mahy N. Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited. Curr. Med. Chem. 2016;23:4753&#x2013;4772. doi: 10.2174/0929867324666161123091314.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867324666161123091314</ArticleId><ArticleId IdType="pubmed">27881068</ArticleId></ArticleIdList></Reference><Reference><Citation>Waisman A., Hauptmann J., Regen T. The role of IL-17 in CNS diseases. Acta Neuropathol. 2015;129:625&#x2013;637. doi: 10.1007/s00401-015-1402-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1402-7</ArticleId><ArticleId IdType="pubmed">25716179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuestner R.E., Taft D.W., Haran A., Brandt C.S., Brender T., Lum K., Harder B., Okada S., Ostrander C.D., Kreindler J.L., et al. Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J. Immunol. 2007;179:5462&#x2013;5473. doi: 10.4049/jimmunol.179.8.5462.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.8.5462</ArticleId><ArticleId IdType="pmc">PMC2849293</ArticleId><ArticleId IdType="pubmed">17911633</ArticleId></ArticleIdList></Reference><Reference><Citation>Siffrin V., Radbruch H., Glumm R., Niesner R., Paterka M., Herz J., Leuenberger T., Lehmann S.M., Luenstedt S., Rinnenthal J.L., et al. In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity. 2010;33:424&#x2013;436. doi: 10.1016/j.immuni.2010.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.08.018</ArticleId><ArticleId IdType="pubmed">20870176</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Ke K.F., Liu Z., Qiu Y.H., Peng Y.P. Th17 cell-mediated neuroinflammation is involved in neurodegeneration of abeta1-42-induced Alzheimer&#x2019;s disease model rats. PLoS ONE. 2013;8:e75786. doi: 10.1371/journal.pone.0075786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075786</ArticleId><ArticleId IdType="pmc">PMC3790825</ArticleId><ArticleId IdType="pubmed">24124514</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D.D., Kuchroo V.K. Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions. Immunity. 2015;43:1040&#x2013;1051. doi: 10.1016/j.immuni.2015.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.12.003</ArticleId><ArticleId IdType="pubmed">26682981</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpe E., Battistini L., Borsellino G. Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis. Mediat. Inflamm. 2015;2015:475158. doi: 10.1155/2015/475158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/475158</ArticleId><ArticleId IdType="pmc">PMC4685148</ArticleId><ArticleId IdType="pubmed">26770017</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamagata T., Skepner J., Yang J. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases. Arch. Immunol. Ther. Exp. 2015;63:405&#x2013;414. doi: 10.1007/s00005-015-0362-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-015-0362-x</ArticleId><ArticleId IdType="pubmed">26358867</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly K., Smith M.P., Thibodeaux Q., Reddy V., Liao W., Bhutani T. Anti IL-17 in psoriasis. Expert Rev. Clin. Immunol. 2019;15:1185&#x2013;1194. doi: 10.1080/1744666X.2020.1679625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1744666X.2020.1679625</ArticleId><ArticleId IdType="pubmed">31603358</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S., Miranda C.J., Braun L., Meyer K., Frakes A.E., Ferraiuolo L., Likhite S., Bevan A.K., Foust K.D., McConnell M.J., et al. Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat. Med. 2016;22:397&#x2013;403. doi: 10.1038/nm.4052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4052</ArticleId><ArticleId IdType="pmc">PMC4823173</ArticleId><ArticleId IdType="pubmed">26928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Liu Y., Niu Y., Xu Y., Zhou Q., Xu X., Wang J., Yu M. Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson&#x2019;s disease patients. Neurosci. Lett. 2017;648:21&#x2013;25. doi: 10.1016/j.neulet.2017.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.03.045</ArticleId><ArticleId IdType="pubmed">28359932</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie K., Zhang Y., Gan R., Wang L., Zhao J., Huang Z., Tang H., Wang L. Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson&#x2019;s disease with cognitive impairment in the Han Chinese population. Neurosci. Lett. 2013;541:111&#x2013;115. doi: 10.1016/j.neulet.2013.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.02.024</ArticleId><ArticleId IdType="pubmed">23485736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Lee W.W., Kim S.H., Kang Y., Lee N., Shin M.S., Kang S.W., Kang I. Age-associated alteration in naive and memory Th17 cell response in humans. Clin. Immunol. 2011;140:84&#x2013;91. doi: 10.1016/j.clim.2011.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2011.03.018</ArticleId><ArticleId IdType="pmc">PMC3115516</ArticleId><ArticleId IdType="pubmed">21489886</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell J.D., Foerster A., Lasmanowicz V., Niemoller M., Scheffold A., Fahrendorff M., Rauser G., Assenmacher M., Richter A. Rapid detection, enrichment and propagation of specific T cell subsets based on cytokine secretion. Clin. Exp. Immunol. 2011;163:1&#x2013;10. doi: 10.1111/j.1365-2249.2010.04261.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2010.04261.x</ArticleId><ArticleId IdType="pmc">PMC3010906</ArticleId><ArticleId IdType="pubmed">20964638</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>